share_log

*ST景峰(000908.SZ):拟开展委托研发

*ST Jingfeng (000908.SZ): Intends to carry out commissioned research and development.

Gelonghui Finance ·  Oct 18, 2024 21:16

Gelonghui, October 18th | *ST Jingfeng (000908.SZ) announced that, according to the development needs, the company and its holding subsidiaries plan to engage in related-party entrusted research and development with the subsidiary of the related party CSPC Pharma Holdings Co., Ltd. (referred to as "CSPC Pharma Group"), named CSPC Pharma Group Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. (referred to as "CSPC Zhongqi"), with a total expected transaction amount not exceeding 10 million yuan. The above limit is valid for three years from the date of approval by the board of directors.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment